DIVIS LABS LIMITED is a reputable Indian manufacturer of Active Pharmaceutical Ingredients (APIs). The company was founded in 1990 with a sporadic growth of employees currently at 13,884 in 2020. In terms of market value, they have ranked the second most valuable pharmaceutical company in India.
Some of their products include naproxen, gabapentin, dextromethorphan HBr among others. They are high research-oriented and frequently launch new and improved ingredients as well as intermediates. They accrue a net income of USD 1.2 billion (R1,819.46crore) in 2020.
